Clinical Trial Update: Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause [Phase 2]

View source ↗

Summary

A Phase 2 NICHD-sponsored trial evaluating the synthetic hormone CDB-2914 for menopausal symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopause

Drugs mentioned

• CDB-2914 (Ulipristal acetate)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Postmenopause | Phase 2 | Status: COMPLETED